Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bribery scandal will hit Glaxo's China growth
CNN Money
Wednesday, July 24, 2013 - 9:59am
tags:
China, GSK
Roche Says GA101 Beat Rituxan in Test as Replacement Drug
Bloomberg
Wednesday, July 24, 2013 - 9:57am
tags:
Roche, GA101, Rituxan, chronic lymphocytic leukemia
Biogen shares slip on MS patient death, company says no connection
Marketwatch
Wednesday, July 24, 2013 - 9:56am
tags:
Biogen Idec, MS, multiple sclerosis, Tecfidera
Sarepta To Seek Early U.S. Approval For Muscular Dystrophy Drug
TheStreet.com
Wednesday, July 24, 2013 - 9:54am
tags:
Sarepta, FDA, Duchenne Muscular Dystrophy, eteplirsen
The Medicines Company Reports Second Quarter and First Half 2013 Financial Results
Yahoo
Wednesday, July 24, 2013 - 9:52am
tags:
earnings, The Medicines Company
FDA advisory panel votes against new use of AbbVie's Humira
Reuters
Wednesday, July 24, 2013 - 9:51am
tags:
FDA, advisory panels, AbbVie, Humira, spondyloarthritis
FDA panel narrowly backs new use of UCB's arthritis drug
Reuters
Wednesday, July 24, 2013 - 9:49am
tags:
FDA, UCB Pharmaceuticals, rheumatoid arthritis, certolizumab
3 Biotech Catalysts Primed To Be Successful In Q3
Seeking Alpha
Wednesday, July 24, 2013 - 9:48am
tags:
BIOD-123, Biodel, MannKind, Afrezza, GTx
Biogen Idec Earnings Preview: Get Ahead of the Analysts
Wall St. Cheat Sheet
Wednesday, July 24, 2013 - 9:45am
tags:
BiogenIdec, earnings
Illumina says 2Q net income spikes, lifts outlook
Yahoo/AP
Wednesday, July 24, 2013 - 9:44am
tags:
earnings, Illumina
VIVUS Names New CEO and Chairman
Motley Fool
Wednesday, July 24, 2013 - 9:44am
tags:
Vivus, Anthony Zook
Novartis vaccine division hit by Bexsero setback
Reuters
Wednesday, July 24, 2013 - 9:42am
tags:
Novartis, vaccines, Bexsero
Merck announces FDA acceptance of new drug application for vorapaxar
Yahoo/Fly on the Wall
Wednesday, July 24, 2013 - 9:35am
tags:
Merck, FDA, Vorapaxar
Eli Lilly Tops Earnings Estimates, Raises FY Guidance Comment Now Follow Comments
Forbes
Wednesday, July 24, 2013 - 9:31am
tags:
earnings, Eli Lilly
Merck Needs Acquisitions: Here's The List
Seeking Alpha
Tuesday, July 23, 2013 - 12:07pm
tags:
Merck, M&A, Celgene, Dendreon, Endocyte, Immunomedics, Isis Pharmaceuticals, Vical, ONYX Pharmaceuticals
Ironwood Pharma 2Q loss widens, revenue slides
Yahoo/AP
Tuesday, July 23, 2013 - 11:56am
tags:
earnings, Ironwood Pharmaceuticals
XenoPort announce inclusion of Horizant in new treatment guidelines
Yahoo/Fly on the Wall
Tuesday, July 23, 2013 - 11:20am
tags:
XenoPort, Horizant
Athersys, Inc.: Clinical Trial For Inflammatory Bowel Disease
Seeking Alpha
Tuesday, July 23, 2013 - 11:19am
tags:
Athersys, inflammatory bowel disease, clinical trials, MultiStem, stem cells
Earnings Increase Expected for Celgene (CELG)
Forbes
Tuesday, July 23, 2013 - 11:18am
tags:
earnings, Celgene
Array Seeks Asthma Drug Partner Following Mid-Stage Study Results
TheStreet.com
Tuesday, July 23, 2013 - 11:17am
tags:
asthma, Array Biopharma, Merck, Amgen, ARRY-502

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.